| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13D · 1 security · may seek to influence control | ||||||
|
Enzo Biochem, Inc.
13D
ENZB · 294100102
|
21.8% |
6/30/2025
Event 6/23/2025
|
||||
| Battery Ventures XIV, L.P. | 21.8% | |||||
| Battery Ventures XIV-EF, L.P. | 21.8% | |||||
| Battery Investment Partners XIV, L.P. | 21.8% | |||||
| Battery Partners XIV, L.P. | 21.8% | |||||
| Battery Partners GP XIV, LLC | 21.8% | |||||
| Neeraj Agrawal | 21.8% | |||||
| Michael M. Brown | 21.8% | |||||
| Morad Elhafed | 21.8% | |||||
| Jesse Feldman | 21.8% | |||||
| Russell L. Fleischer | 21.8% | |||||
| Roger H. Lee | 21.8% | |||||
| Zachary Smotherman | 21.8% | |||||
| Chelsea R. Stoner | 21.8% | |||||
| Dharmesh Thakker | 21.8% | |||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.